2m 2m 2m 2m 2m 2m 2m
Syndax Pharmaceu (SNDX)
NASDAQ
$19.65-$0.005 (-0.03%)
Price as of Aug 21, 2026 7:30 PM EDT- $1.8BMarket Cap
- 21.00%1-Year Change
- BiotechnologyIndustry
Syndax Pharmaceu (SNDX)
$19.65-$0.005 (-0.03%)
SNDX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $19.65 | ||
Change | -$0.10 (-0.51%) | ||
Open | $19.93 | ||
High | $20.28 | ||
Low | $19.25 | ||
Previous Close | $19.75 | ||
Volume | 1,695,907 | ||
30-Day Average Volume | 1,359,832 | ||
1-Week Change | -0.96% | ||
1-Month Change | -13.21% | ||
1-Year Change | 21.00% | ||
3-Year Change | 6.27% | ||
5-Year Change | 24.76% | ||
Fundamentals | |||
Shares Outstanding | 89.3M | ||
Total Assets | $703.7M | ||
Market Cap | $1.8B | ||
Enterprise Value | $2.6B | ||
Period: QTR TTM FY | |||
Revenue | $54.7M | ||
Net Income | -$49.4M | ||
Free Cash Flow | -$30.3M | ||
EBIT | -$37.3M | ||
EBITDA | -$32.3M | ||
Net Working Capital | $575.4M | ||
EPS | -$0.55 | ||
Enterprise Value/EBITDA | -81 | ||
Enterprise Value/Revenue | 48 | ||
P/B | 116 | ||
P/E | -36 | ||
PEG | 2 | ||
Price/Free Cash Flow | -58 | ||
Price/Operating Cash Flow | -58 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue